Ignite Creation Date:
2024-05-06 @ 8:09 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02679170
Status:
COMPLETED
Last Update Posted:
2022-06-10
First Post:
2016-02-05
Brief Title:
Study to IDEntify Patients With AdvancedMetastatic Non Small Cell Lung Cancer NSCLC and ALK and ROS1 Translocation and to Establish Their Therapeutic Management IDEALKROS
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A8081057
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None